Bracco Imaging, through its business unit Bracco Injeneering SA, has announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system that puts the radiologic technologist in control in the computed tomography suite.
The EmpowerCTA+ was first launched in the USA, then gradually in Europe, and was presented at the European Congress of Radiology (ECR, Vienna, 4–8 March 2015).
The EmpowerCTA+ contrast injection system has been reengineered, setting a new standard in the contrast power injectors market. The system was designed to streamline workflow, with enhanced safety and control at the patient side.
EmpowerCTA+ ‘s advanced touchscreen technology enables technologists to customise the contrast injection experience right at the patient’s side with new enhancements, including real time variable flow rates, saline advance, and saline jump.
“We are extremely pleased to announce the availability on the market of the EmpowerCTA+,“ said Vittorio Puppo, head of business unit injectors and president and CEO at Bracco Diagnostics. “The contrast injector system was reengineered with digital touch technology and a new visionary design with high performance, which will help us to increase market penetration.”
EmpowerCTA+ has a saline advance function which tests a patient’s patency and vein integrity while its saline jump feature minimizes the amount of contrast a patient receives. The injector’s unique patented EDA™ (extravasation detection accessory) advances patient care while providing additional safety and peace of mind for the technologist. In addition, its eGFR calculator simplifies calculations for kidney evaluation function prior to contrast delivery. The risk of air embolisms to the patient is reduced due to the system’s built-in tilt sensor and lock. Technologists have greater control with the touchscreen technology at the patient’s side.